Caux C, Moreau I, Saeland S, Banchereau J
Schering-Plough, Laboratory for Immunological Research, Dardilly, France.
Blood. 1992 May 15;79(10):2628-35.
Numerous studies have shown that interferon-gamma (IFN gamma) inhibits the proliferative effects of colony-stimulating factors (CSFs) on human bone marrow cells. In the present study we investigated the effects of IFN gamma and other described inhibitory factors on the proliferation of highly purified CD34+ human hematopoietic progenitor cells (HPC) in response to recombinant CSFs. While transforming growth factor-beta (TGF beta) and IFN alpha were highly inhibitory, IFN gamma strongly potentiated interleukin-3 (IL-3) and, to a lesser extent, granulocyte-macrophage-CSF (GM-CSF) induced growth of CD34+ HPC. IFN gamma had no significant proliferative effect per se, and did not affect granulocyte-CSF (G-CSF)-dependent cell proliferation. Within 10 days the number of viable cells generated in the presence of IL-3 + IFN gamma was two times higher than in the presence of IL-3 alone. Limiting dilution analysis showed that IFN gamma acts directly on its target cell to increase the frequency of IL-3-responding cells without affecting the average size of the IL-3-dependent clones. Enhanced frequency of IL-3- and GM-CSF-responding cells was also observed in colony assays where the addition of IFN gamma increased by twofold to threefold the number of granulocyte colony-forming units (CFU-G), macrophage CFUs (CFU-M), granulocyte-macrophage CFUs (CFU-GM), and mixed erythroid (E-MIX). In contrast, IFN gamma did not affect the generation of erythroid burst-forming units (BFU-e) in such cultures. In longer-term culture, the combination of IFN gamma and IL-3 did not alter the lineage distribution of the cells when compared with IL-3 alone. However, after 15 days, when mature cells were present in the cultures, IFN gamma displayed cell concentration-related growth-inhibitory effects. Thus, IFN gamma appears to stimulate the early stage of myelopoiesis by enhancing the frequency of growth factor-responding cells but, unlike tumor necrosis factor alpha (TNF alpha), does not alter cell differentiation.
大量研究表明,γ干扰素(IFNγ)可抑制集落刺激因子(CSF)对人骨髓细胞的增殖作用。在本研究中,我们调查了IFNγ和其他已描述的抑制因子对高度纯化的CD34 +人造血祖细胞(HPC)在重组CSF刺激下增殖的影响。虽然转化生长因子-β(TGFβ)和α干扰素具有高度抑制作用,但IFNγ能显著增强白细胞介素-3(IL-3)的作用,在较小程度上还能增强粒细胞-巨噬细胞集落刺激因子(GM-CSF)诱导的CD34 + HPC生长。IFNγ本身没有显著的增殖作用,也不影响粒细胞集落刺激因子(G-CSF)依赖的细胞增殖。在10天内,IL-3 + IFNγ存在时产生的活细胞数量比单独使用IL-3时高出两倍。极限稀释分析表明,IFNγ直接作用于其靶细胞,增加对IL-3有反应的细胞频率,而不影响IL-3依赖克隆的平均大小。在集落试验中也观察到对IL-3和GM-CSF有反应的细胞频率增加,其中添加IFNγ使粒细胞集落形成单位(CFU-G)、巨噬细胞集落形成单位(CFU-M)、粒细胞-巨噬细胞集落形成单位(CFU-GM)和混合红系集落(E-MIX)的数量增加了两倍至三倍。相比之下,IFNγ在这种培养中不影响红系爆式集落形成单位(BFU-e)的产生。在长期培养中,与单独使用IL-3相比,IFNγ和IL-3的组合不会改变细胞的谱系分布。然而,15天后,当培养物中出现成熟细胞时,IFNγ表现出与细胞浓度相关的生长抑制作用。因此,IFNγ似乎通过增加生长因子反应细胞的频率来刺激髓系造血的早期阶段,但与肿瘤坏死因子-α(TNFα)不同,它不会改变细胞分化。